{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:56:18Z","timestamp":1792007778148,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":95,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005860","name":"Helsefonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.100964","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:50:25Z","timestamp":1775843425000},"page":"100964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quality of Life in Patients With Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"5","author":[{"given":"Emilie Eifer","family":"M\u00f8ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-6539","authenticated-orcid":false,"given":"Rasmus Hvidbjerg","family":"Gantzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Celia","family":"Herting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Mellemkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias Hauge","family":"B\u00f6tcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Peter","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger Jon","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9904","key":"10.1016\/j.gastha.2026.100964_bib1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gastha.2026.100964_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gastha.2026.100964_bib3","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gastha.2026.100964_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2026.100964_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2023.102251","article-title":"Clinical factors associated with illness perception, worry and mental health in sclerosing cholangitis: a single centre prospective study","volume":"48","author":"Nayagam","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2026.100964_bib6","article-title":"Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis","volume":"3","author":"Saffioti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gastha.2026.100964_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12955-018-0951-6","article-title":"Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review","volume":"16","author":"Isa","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.gastha.2026.100964_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12955-021-01739-3","article-title":"Quality of life in primary sclerosing cholangitis: a systematic review","volume":"19","author":"Marcus","year":"2021","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.gastha.2026.100964_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOG.0000000000001075","article-title":"Assessing patient-reported outcomes in primary sclerosing cholangitis: an update","volume":"41","author":"Evon","year":"2025","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.gastha.2026.100964_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/liv.15542","article-title":"Health-related quality of life in patients with primary sclerosing cholangitis: a longitudinal population-based cohort study","volume":"43","author":"Mol","year":"2023","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.gastha.2026.100964_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.29664","article-title":"Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: the PSC PRO","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.gastha.2026.100964_bib12","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/liv.13216","article-title":"Prognostic biomarkers and surrogate end points in PSC","volume":"36","author":"Vesterhus","year":"2016","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.gastha.2026.100964_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/apt.16296","article-title":"Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis","volume":"53","author":"Mazhar","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2026.100964_bib14","article-title":"Macrophage activation markers, soluble CD163 and mannose receptor, in liver fibrosis","volume":"7","author":"Gantzel","year":"2020","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.gastha.2026.100964_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/cells9051175","article-title":"Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure","volume":"9","author":"Nielsen","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.gastha.2026.100964_bib16","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000315","article-title":"Circulating macrophage activation markers predict transplant-free survival in patients with primary sclerosing cholangitis","volume":"12","author":"Bossen","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"10.1016\/j.gastha.2026.100964_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2026.100964_bib18","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gastha.2026.100964_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2026.100964_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.gastha.2026.100964_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"4","key":"10.1016\/j.gastha.2026.100964_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/003655102760145852","article-title":"Characterization of an enzyme-linked immunosorbent assay for soluble CD163","volume":"62","author":"M\u00f8ller","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.gastha.2026.100964_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"Moller","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.gastha.2026.100964_bib24","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/hep4.2065","article-title":"Development and validation of the Cirrhotic Ascites Severity model\u2014a patient-reported outcome-based model to predict 1-year mortality","volume":"6","author":"Gantzel","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastha.2026.100964_bib25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/apt.70054","article-title":"Patient reported outcomes in primary sclerosing cholangitis: an Australian perspective","volume":"61","author":"Tan","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2026.100964_bib26","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/apt.70151","article-title":"Editorial: when and what to ask-capturing the symptoms experienced by patients with PSC. Authors' reply","volume":"61","author":"Tan","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2026.100964_bib27","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/apt.70127","article-title":"Editorial: when and what to ask-capturing the symptoms experienced by patients with PSC","volume":"61","author":"Bowlus","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gastha.2026.100964_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/14034948211058060","article-title":"Danish population health measured by the EQ-5D-5L","volume":"51","author":"Jensen","year":"2023","journal-title":"Scand J Public Health"},{"issue":"7","key":"10.1016\/j.gastha.2026.100964_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00042737-199907000-00015","article-title":"Immunohistochemical analysis of inflammation in primary sclerosing cholangitis","volume":"11","author":"Ponsioen","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2026.100964_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-9120(01)00215-6","article-title":"Accumulation of macrophages in primary sclerosing cholangitis","volume":"34","author":"Cameron","year":"2001","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.gastha.2026.100964_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/JLB.3A1218-500R","article-title":"The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms","volume":"106","author":"Nielsen","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.gastha.2026.100964_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2288-11-62","article-title":"Effect of questionnaire length, personalisation and reminder type on response rate to a complex postal survey: randomised controlled trial","volume":"11","author":"Sahlqvist","year":"2011","journal-title":"BMC Med Res Methodol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:50:25Z","timestamp":1781023825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326000853"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100964","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Patients With Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"100964"}}